ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression Cell
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 60% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
Agitation and aggression related pathology Studies on agitation and aggression in AD have identified various neuronal and functional changes, including atrophy, low fractional anisotropy scores, increased functional connectivity, amyloid accumulation, and hypometabolism in regions such as the amygdala, anterior cingulate, hippocampus, frontal insula, and frontal cortex (Tekin et al., 2001
The treatment only lasts 45-60 minutes
kidney, or liver conditions may also need to avoid it or use a lower dose